Author's reply

Comment

Samim Emet et al. Anatol J Cardiol. 2015 Feb.

. 2015 Feb;15(2):162-3.

No abstract available

Comment on

Relationship between brain natriuretic peptide, microalbuminuria, and contrast-induced nephropathy in patients with acute coronary syndrome.
Yildiz E, Köse M, Yürüyen G, Akpinar TS, Emet S, Erdem E, Tükek T. Yildiz E, et al. Anadolu Kardiyol Derg. 2014 Sep;14(6):505-10. doi: 10.5152/akd.2014.4931. Anadolu Kardiyol Derg. 2014. PMID: 25233496
Contrast nephropathy in patients with well-preserved renal function.
Tekin G, Tekin A. Tekin G, et al. Anatol J Cardiol. 2015 Feb;15(2):161-2. doi: 10.5152/akd.2015.5965. Epub 2015 Jan 21. Anatol J Cardiol. 2015. PMID: 25625447 Free PMC article. No abstract available.

1. Yıldız E, Köse M, Yürüyen G, Akpınar TS, Emet S, Erdem E, et al. Relationship between brain natriuretic peptide, microalbuminuria, and contrast-induced nephropathy in patients with acute coronary syndrome. Anatolian J Cardiol. 2014;14:505–10. [CrossRef] - PubMed
1. Barrett BJ, Parfrey PS. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med. 1994;331:1449–50. [CrossRef] - PubMed
1. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989;320:143–9. [CrossRef] - PubMed
1. Schwab SJ, Hlatky MA, Pieper KS, Davidson CJ, Morris KG, Skelton TN, et al. Contrast nephrotoxicity:a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. N Engl J Med. 1989;320:149–53. [CrossRef] - PubMed
1. Kolonko A, Kokot F, Wiecek A. Contrast-associated nephropathy-old clinical problem and new therapeutic perspectives. Nephrol Dial Transplant. 1998;13:803–6. [CrossRef] - PubMed